Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Rhabdomyosarcoma 1PRETEXT I Hepatoblastoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Neoplasm Metastasis 1Endometrial Adenocarcinoma 1Desmoplastic Small Round Cell Tumor 1Brain Neoplasms 1Advanced Rare Tumours 1Advanced Cancer 1Adult Solid Neoplasm 1

Interventions

temsirolimus 1Vorinostat 1Sirolimus 1Everolimus 1Clinical Trials, Phase IV as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Advanced Cancer × temsirolimus × Clear all
NCT01087554 2026-01-16

Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
249 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡